SMTL ID : 7q5o.1

Bromodomain-containing 2 BD2 in complex with the inhibitor CRCM5484

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.52 Å

Oligo State

monomer

Ligands

1 x 8M6: 2-[[11-ethanoyl-4-(furan-2-ylmethyl)-3-oxidanylidene-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-5-yl]sulfanyl]-~{N}-(2-methylpyridin-3-yl)ethanamide(Non-covalent)

8M6.1: 12 residues within 4Å: Chain A: W.26, P.27, F.28, V.32, A.36, L.37, L.39, C.81, N.85, H.89, D.90, V.91 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.28, A:V.32, A:L.37, A:D.90, A:V.91 Hydrogen bonds: A:N.85

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 3 residues within 4Å: Chain A: K.58, D.63, E.69 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.58, A:K.58 EDO.3: 4 residues within 4Å: Chain A: Q.99, D.100, E.103, F.104 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.100, A:D.100 EDO.4: 1 residues within 4Å: Chain A: R.62 1 PLIP interactions: 1 interactions with chain A Water bridges: A:A.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carrasco, K. et al., CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation. J.Med.Chem. (2022)

Release Date

2022-04-20

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 2